Interesting article published in February of this year looks at problem of prescription drugs in water supplies.
The available data indicate that there is a substantial margin of
safety between the
very low concentrations of pharmaceuticals in
drinking-water and the minimum therapeutic doses.
Based on this finding, the World Health Organization (WHO) deems it unnecessary
to develop formal contamination standard values for pharmaceuticals in its
Guidelines for drinking-water quality; and concerns
over pharmaceuticals in drinking-water should not divert water suppliers and
regulators from other priorities for drinking-water safety, most notably
microbial risks such as bacterial, viral and protozoan pathogens, and
other chemical risks such as naturally occurring arsenic and excessive levels
of fluoride [1, 2].
I will take issue with the WHO conclusion that drugs and their
breakdown products are too low to impact human health. The drugs most
frequently appear in drinking water as mixtures whose combined effect have not
been considered by health authorities even though such mixtures have been shown
to be biologically active in aquatic organisms as discussed in this article.
(Synergistic effects due to mixtures of low concentrations of environmental
pollutants are already well recognized, see [3] Super-Toxic Cocktails,
SiS 43).
Among the drugs identified in water supplies are antibiotics,
analgesics and anti-inflammatories, beta-blockers, hormones, statins, selective
serotonin reuptake inhibitorsantiepileptic, diuretics, anti-asthmatics, antidepressants,
antineoplastics, antipsychotics, stimulants, sedatives, and anticoagulants [4, 5].
Read more at www.i-sis.org.uk
See also:
Antidepressants in water trigger autism genes in fish
Pharmaceuticals and Personal Care Products as Pollutants (EPA web page)
WHO/Pharmaceuticals in drinking-water (downloadable report from WHO)